Please check your internet connection and try again.
## Septran (Co-trimoxazole)
### Overview
Septran is a combination antibiotic containing sulfamethoxazole and trimethoprim, which work synergistically to inhibit bacterial folic acid synthesis.
### Primary Indications
* Urinary tract infections (UTIs)
* Pneumocystis jirovecii pneumonia (PJP) prophylaxis and treatment
* Bacterial infections such as otitis media, bronchitis, and shigellosis.
### Adult Dosing
* **UTIs:** 160 mg trimethoprim/800 mg sulfamethoxazole (1 DS tablet) twice daily for 3 days.
* **PJP Treatment:** 15-20 mg/kg/day of trimethoprim component, divided into 3 or 4 doses, administered over 14-21 days.
* **PJP Prophylaxis:** 1 DS tablet once daily or 1 DS tablet three times weekly. Specific regimens depend on patient factors and local guidelines.
### Pediatric Dosing
Dosing is based on the trimethoprim component.
* **General Infections:** 8-10 mg/kg/day of trimethoprim component, divided into two doses.
* **PJP Treatment:** 15-20 mg/kg/day of trimethoprim component, divided into 3 or 4 doses.
* **PJP Prophylaxis:** 5 mg/kg/day of trimethoprim component, divided into two doses, administered on alternate days or 3 times weekly. Specific regimens depend on patient factors and local guidelines.
* *Note: Pediatric dosing for specific indications may vary; always consult relevant guidelines.*
### Dose Adjustments
* **Renal Impairment:** Dose adjustment is necessary in patients with significant renal impairment. Consult prescribing information for specific recommendations based on creatinine clearance.
### Contraindications
* Known hypersensitivity to trimethoprim, sulfamethoxazole, or sulfonamides.
* Documented megaloblastic anemia due to folate deficiency.
* Infants less than 2 months of age (due to risk of kernicterus).
* Severe renal or hepatic insufficiency.
* History of drug-induced immune thrombocytopenia with prior use of sulfonamides or trimethoprim.
### Adverse Effects
Common adverse effects include rash, nausea, vomiting, and diarrhea. Serious adverse effects can include Stevens-Johnson syndrome, toxic epidermal necrolysis, aplastic anemia, agranulocytosis, thrombocytopenia, hyperkalemia, and hepatic necrosis.
### Key Drug Interactions
* **Warfarin:** Increased INR; monitor INR closely.
* **Methotrexate:** Increased risk of myelosuppression; monitor CBC.
* **ACE inhibitors/ARBs/Potassium-sparing diuretics:** Increased risk of hyperkalemia.
* **Tricyclic antidepressants:** Reduced efficacy.
### Monitoring
* Complete blood counts (CBC) with differential, especially with prolonged therapy or in immunocompromised patients.
* Renal and hepatic function.
* Electrolytes, particularly potassium.
* Signs of hypersensitivity reactions.
### Clinical Pearls
* Co-trimoxazole should be taken with plenty of fluids to prevent crystalluria.
* Photosensitivity is a known side effect; advise patients to use sun protection.
* Consider folic acid supplementation (5-10 mg daily) in patients receiving prolonged therapy to minimize hematologic toxicity, particularly in those with folate deficiency or increased requirements.
***
*Disclaimer: This information is intended for healthcare professionals and does not replace a thorough review of the current prescribing information and relevant clinical guidelines. Always verify drug information with the most current product literature and institutional protocols.*
